[Caplacizumab combined with therapeutic plasma exchange, glucocorticoids, and rituximab for refractory thrombotic thrombocytopenic purpura: a case report and literature review]
{{output}}
The clinical course and management of a patient with refractory immune thrombotic thrombocytopenic purpura (iTTP) admitted to the Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, were retrospectiv... ...
